Novo Alle 1
Bagsvaerd 2880
Denmark
45 44 44 88 88
https://www.novonordisk.com
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 66.015
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Lars Fruergaard Jorgensen | President, CEO & Member of Management Board | 4,65M | N/A | 1966 |
Mr. Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board | 1,84M | N/A | 1971 |
Mr. Henrik Ehlers Wulff | Executive VP of Product Supply, Quality & IT and Member of the Management Board | 1,86M | N/A | 1970 |
Ms. Camilla Sylvest | Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board | 1,81M | N/A | 1972 |
Dr. Martin Holst Lange | Executive VP of Development & Member of the Management Board | 1,76M | N/A | 1970 |
Dr. Marcus Schindler Ph.D. | EVP of Research & Early Development, Chief Scientific Officer & Member of the Management Board | 1,76M | N/A | 1966 |
Mr. Maziar Mike Doustdar | Executive VP of International Operations & Member of the Management Board | N/A | N/A | 1970 |
Mr. Douglas J. Langa | Executive VP of North America Operations & Member of Management Board | N/A | N/A | 1966 |
Mr. Ludovic Helfgott | Executive VP, Head of Rare Disease & Member of Management Board | N/A | N/A | 1974 |
Ms. Tania Sabroe | Executive VP of Global People & Organisation and Member of Management Board | N/A | N/A | 1977 |
O QualityScore de governança da ISS da Novo Nordisk A/S a partir de 1 de maio de 2024 é 1. As principais pontuações para Auditoria são: 3; Conselho: 2; Direitos de Acionistas: 9; Compensação: 1.